miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1

被引:44
作者
Liu, Zengyan [1 ,2 ]
Zhang, Guoqiang [3 ]
Yu, Wenzheng [2 ]
Gao, Na [2 ]
Peng, Jun [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Hematol, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China
[2] Binzhou Med Univ, Dept Hematol, 661 Second Huanghe St, Binzhou 256603, Peoples R China
[3] Binzhou Med Univ, Dept Thyroid & Breast Surg, 661 Second Huanghe St, Binzhou 256603, Peoples R China
关键词
miR-186; Jagged1; Multiple myeloma; Proliferation; LUNG-CANCER CELLS; DISEASE PROGRESSION; DOWN-REGULATION; EXPRESSION; MICRORNA; SURVIVAL; GROWTH; METASTASIS; NOTCH; BIOGENESIS;
D O I
10.1016/j.bbrc.2015.11.136
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) are small, noncoding ribonucleic acids that regulate gene expression by targeting mRNAs for translational repression and degradation. Accumulating experimental evidence supports a causal role of miRNAs in hematology tumorigenesis. However, the specific functions of miRNAs in the pathogenesis of multiple myeloma (MM) remain to be established. In this study, we demonstrated that miR-186 is commonly downregulated in MM cell lines and patient MM cells. Ectopic expression of miR-186 significantly inhibited cell growth, both in vitro and in vivo, and induced cell cycle G0/G1 arrest. Furthermore, miR-186 induced downregulation of Jagged1 protein expression by directly targeting its 3'-untranslated region (3'-UTR). Conversely, overexpression of Jagged1 rescued cells from miR-186-induced growth inhibition. Our collective results clearly indicate that miR-186 functions as a tumor suppressor in MM, supporting its potential as a therapeutic target for the disease. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:692 / 697
页数:6
相关论文
共 36 条
[1]  
Agarwal Amit, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P2
[2]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[3]   Oncogenomics to Target Myeloma in the Bone Marrow Microenvironment [J].
Anderson, Kenneth C. .
CLINICAL CANCER RESEARCH, 2011, 17 (06) :1225-1233
[4]   Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[5]   Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome [J].
Avet-Loiseau, Herve ;
Attal, Michel ;
Moreau, Philippe ;
Charbonnel, Catherine ;
Garban, Frederic ;
Hulin, Cyrille ;
Leyvraz, Serge ;
Michallet, Mauricette ;
Yakoub-Agha, Ibrahim ;
Garderet, Laurent ;
Marit, Gerald ;
Michaux, Lucienne ;
Voillat, Laurent ;
Renaud, Marc ;
Grosbois, Bernard ;
Guillerm, Gaelle ;
Benboubker, Lotfi ;
Monconduit, Mathieu ;
Thieblemont, Catherine ;
Casassus, Philippe ;
Caillot, Denis ;
Stoppa, Anne-Marie ;
Sotto, Jean-Jacques ;
Wetterwald, Marc ;
Dumontet, Charles ;
Fuzibet, Jean-Gabriel ;
Azais, Isabelle ;
Dorvaux, Veronique ;
Zandecki, Marc ;
Bataille, Regis ;
Minvielle, Stephane ;
Harousseau, Jean-Luc ;
Facon, Thierry ;
Mathiot, Claire .
BLOOD, 2007, 109 (08) :3489-3495
[6]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[7]   miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin [J].
Bi, Yueyang ;
Han, Yong ;
Bi, Haiyang ;
Gao, Fuquan ;
Wang, Xiaozhi .
HUMAN CELL, 2014, 27 (03) :95-102
[8]   To be or notch to be [J].
Brenner, M .
NATURE MEDICINE, 2000, 6 (11) :1210-1211
[9]   miR-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation [J].
Cai, Junchao ;
Wu, Jueheng ;
Zhang, Huizhong ;
Fang, Lishan ;
Huang, Yongbo ;
Yang, Yi ;
Zhu, Xun ;
Li, Rong ;
Li, Mengfeng .
CANCER RESEARCH, 2013, 73 (02) :756-766
[10]  
Chira Panagiota, 2010, Cancers (Basel), V2, P1328, DOI 10.3390/cancers2021328